Science Explorer Back to mapMap
Discussion
Researcher · Oregon Health & Science University · United States

Christopher L. Corless

Christopher L. Corless publishes mostly in Pulmonary and Respiratory Medicine, Gastroenterology and Surgery, on topics such as Gastrointestinal Tumor Research and Treatment, Sarcoma Diagnosis and Treatment and Gastrointestinal disorders and treatments.

ORCID 0000-0003-4871-8364 OpenAlex
World rank
#41,253
of 7,710,434 ranked researchers
Rank in United States
#15,845
of 1,627,098
Works
518
Citations
52k
Citations per work
101.1
h-index
101
i10-index 279Top 0.2% in Pulmonary and Respiratory Medicine
Christopher L. Corless

What does Christopher L. Corless research?

Christopher L. Corless's work is mostly in Medicine (46%), Biochemistry, Genetics and Molecular Biology (12%).

Health Sciences: 241 works · 46.5% of their workMedicine: 241 works · 46.5% of their workPulmonary and Respiratory Medicine: 80 works · 15.4% of their workGastroenterology: 61 works · 11.7% of their workSurgery: 60 works · 11.5% of their workOncology: 41 works · 7.9% of their workEverything else: 212 works · 41.0% of their workLife Sciences: 65 works · 12.5% of their workBiochemistry, Genetics and Molecular Biology: 65 works · 12.5% of their workMolecular Biology: 37 works · 7.1% of their workCancer Research: 28 works · 5.4% of their workTHEIR WORKChristopher L.Corless518works
Life Sciences12%Health Sciences46%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine24146.5%
  2. Everything else21241.0%
    1. Biochemistry, Genetics and Molecular Biology6512.5%
  1. 1Pulmonary and Respiratory Medicine15% of their works
  2. 2Gastroenterology12% of their works
  3. 3Surgery12% of their works
  4. 4Oncology8% of their works
  5. 5Molecular Biology7% of their works
  6. 6Cancer Research5% of their works

Research topics

Which keywords describe Christopher L. Corless's research?

The keywords of their largest research topics: Prognostic Factors, Imatinib Mesylate, Sunitinib, Chemotherapy, Clinical Practice Guidelines, Osteosarcoma, Soft Tissue Sarcoma and Intussusception.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Prognostic Factors2363 topics
  2. Imatinib Mesylate1321 topic
  3. Sunitinib1321 topic
  4. Chemotherapy1102 topics
  5. Clinical Practice Guidelines1102 topics
  6. Osteosarcoma781 topic
  7. Soft Tissue Sarcoma781 topic
  8. Intussusception471 topic
  9. Meckel's Diverticulum471 topic
  10. Cancer Genomics461 topic
  11. Mutational Signatures461 topic
  12. Endoscopic Resection321 topic
  13. Gastric Cancer321 topic
  14. Desmoid Tumor261 topic
  15. Solitary Fibrous Tumor261 topic
  16. Neurofibromatosis241 topic
  17. Tumor Suppressor241 topic
  18. BCR-ABL221 topic
  19. Imatinib221 topic

Where does Christopher L. Corless work?

Christopher L. Corless's main affiliation in the publication record is Oregon Health & Science University, United States.

How many publications and citations does Christopher L. Corless have?

OpenAlex counts 518 works and 52,361 citations for Christopher L. Corless, an h-index of 101, ranking #41,253 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Christopher L. Corless. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.